ISRCTN46326316已完成未知
Comparison between immune response to different modes of vaccination: intradermal and subcutaneous yellow fever vaccination
eiden University Medical Centre (LUMC) (Netherlands)0 个研究点目标入组 155 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 155
研究概览
简要总结
- 2008 results in: http://www.ncbi.nlm.nih.gov/pubmed/18431480 2. 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/30476963 (added 02/09/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Healthy volunteers, greater than 18 years (previously and not previously vaccinated with yellow fever vaccine)
排除标准
- •1. Pregnancy
- •2. Diabetes mellitus
- •3. Use of immunomodulating medication, e.g. corticosteroids
- •4. Cytostatica
- •5. Use of chloroquine
研究者
相似试验
已完成
不适用
Comparison between immune response to different modes of vaccination; intradermal and subcutaneous yellow fever vaccination.(Prevention of) yellow fever.NL-OMON27364eiden University Medical Center, dpt. of Infectious Diseases120
已完成
4 期
The study to compare the immune response between intradermal and intramuscular injection of botulinum toxin AHealthy human volunteersEnzyme-Linked Immunosorbent Assay, Botulinum Toxins, Immunoglobulins, AntibodiesTCTR20211204002Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand100
已完成
4 期
Comparition of immunity and reaction of bOPV vaccine and tOPV vaccine in routine immunization schedule, with or without IPV vaccine administration at DTP3 vaccine contact: A controlled trialCTRI/2013/06/003722World health Organization900
已完成
不适用
Comparative evaluation of immunogenicity and reactogenicity of monovalent type 2 and 3 oral poliovirus vaccines (mOPV 2 and mOPV3) versus trivalent oral poliovirus vaccine (tOPV), and bivalent oral poliovirus vaccine (bOPV) versus monovalent types 1 and 3 oral poliovirus vaccines, respectively: a randomised double-blind trialISRCTN64725429Panacea Biotec Limited (India)900
进行中（未招募）
不适用
ong Term Follow-up (LTFU) study 16-20 yrs after vaccine dose of hepatitis b with/without Hepatitis B immunoglobulin (HBIG) in newborns to Hepatitis B envelope antigen positive (HBeAg+) mothers.Vaccination of healthy newborns of HBsAg+ and/or HBeAg+ mothers against Hepatitis.EUCTR2011-004879-36-Outside-EU/EEAGlaxoSmithKline Biologicals69